BSE nod for 16.21 lakh convertible warrants to promoters of Krsnaa Diagnostics

Fund Raising View source PDF Explain this filing

KRSNAA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹532.55

prior close

₹536.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%-1.1% vs market

Healthcare Service Provider peers, median of 27sector+0.5%-0.8% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.8 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.7

10m

+0.4

15m

+0.4

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3+0.8-1.1+0.5-0.8

Next day

-0.1+1.0-1.1-0.5+0.5

-1.2+1.7-3.0+0.5-1.7

+0.8+0.1+0.8-0.9+1.7

+0.4+0.8-0.4-1.4+1.8

-3.3-0.9-2.4-1.1-2.2

-2.6-4.5+1.9-2.8+0.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Krsnaa Diagnostics received BSE's in-principle approval to issue 16,21,000 convertible warrants to its Promoter and Promoter Group on a preferential basis. Each warrant is convertible into one equity share of face value Rs 5 at an issue price of not less than Rs 566. This is a corrected approval letter from BSE, fixing factual errors in the earlier letter dated October 8, 2026.

Likely market impact

Promoter group will infuse funds and raise their stake once warrants are converted, showing strong promoter confidence in the business.